Younghwa Chun
Gyeonggi-do, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Discovery and Preclinical Evaluation of PBX-7016, a Methylenedioxy-Camptothecin Payload for Antibody-Drug Conjugates with Enhanced Therapeutic Potential.
Journal: Journal of medicinal chemistry
Published: December 19, 2025
Design, synthesis and biological evaluation of camptothecin analogue FL118 as a payload for antibody-drug conjugates in targeted cancer therapy.
Journal: Bioorganic & medicinal chemistry letters
Published: October 30, 2024
Integrative Analyses Reveal the Anticancer Mechanisms and Sensitivity Markers of the Next-Generation Hypomethylating Agent NTX-301.
Journal: Cancers
Published: February 20, 2023
The preclinical efficacy of the novel hypomethylating agent NTX-301 as a monotherapy and in combination with venetoclax in acute myeloid leukemia.
Journal: Blood cancer journal
Published: January 07, 2022
The new obesity-associated protein, neuronal growth regulator 1 (NEGR1), is implicated in Niemann-Pick disease Type C (NPC2)-mediated cholesterol trafficking.
Journal: Biochemical and biophysical research communications
Published: December 02, 2016
Centromere Protein (CENP)-W Interacts with Heterogeneous Nuclear Ribonucleoprotein (hnRNP) U and May Contribute to Kinetochore-Microtubule Attachment in Mitotic Cells.
Journal: PloS one
Published: October 23, 2015
CSN5/JAB1 interacts with the centromeric components CENP-T and CENP-W and regulates their proteasome-mediated degradation.
Journal: The Journal of biological chemistry
Published: August 09, 2013
New centromeric component CENP-W is an RNA-associated nuclear matrix protein that interacts with nucleophosmin/B23 protein.
Journal: The Journal of biological chemistry
Published: October 18, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026